When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation.

about

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation.

Item

http://www.wikidata.org/entity/Q55130319

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

When insulin degludec enhances ...... : a qualitative investigation.

@en

When insulin degludec enhances ...... : a qualitative investigation.

@nl

type

Item

label

When insulin degludec enhances ...... : a qualitative investigation.

@en

When insulin degludec enhances ...... : a qualitative investigation.

@nl

prefLabel

When insulin degludec enhances ...... : a qualitative investigation.

@en

When insulin degludec enhances ...... : a qualitative investigation.

@nl

P1476

When insulin degludec enhances ...... : a qualitative investigation.

@en

P2093

Alexia Marrel

http://www.w3.org/2001/XMLSchema#string

Athena Philis-Tsimikas

http://www.w3.org/2001/XMLSchema#string

Elisabeth Constam

http://www.w3.org/2001/XMLSchema#string

James Weatherall

http://www.w3.org/2001/XMLSchema#string

Jonas Håkan-Bloch

http://www.w3.org/2001/XMLSchema#string

Naomi Knoble

http://www.w3.org/2001/XMLSchema#string

Sally Lanar

http://www.w3.org/2001/XMLSchema#string

William H Polonsky

http://www.w3.org/2001/XMLSchema#string

P2860

Type 2 diabetes and quality of life.

Correlates of insulin injection omission

A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.

Understanding the sources of diabetes distress in adults with type 1 diabetes.

Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes

Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.

Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs.

Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review.

PRO development: rigorous qualitative research as the crucial foundation

P2888

s12955-018-0883-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12955-018-0883-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29720273

http://www.w3.org/2001/XMLSchema#string

P932

5932896

http://www.w3.org/2001/XMLSchema#string